A Randomized, Open-Label Study of the Tolerability and Efficacy of One or Three Daily Doses of Ivermectin Plus Diethylcarbamazine and Albendazole (IDA) Versus One Dose of Ivermectin Plus Albendazole (IA) for Treatment of Onchocerciasis.

PLoS neglected tropical diseases(2023)

引用 0|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要